GILD•benzinga•June 10, 2025 at 01:58 PM

'FDA Places Clinical Hold On Gilead's HIV Treatment Trials Of GS-1720 And/Or GS-4182; Hold Due To Identification Of Safety Signal Of Decreases In CD4+T-Cell & Absolute Lymphocyte Counts In Subset Of Participants Getting Combo; Intend To Investigate And Pu

No summary available.

Read the full article from the original source for complete details and context.

Article published on June 10, 2025 by benzinga